A Novel COVID-19 Diagnostic System Using Biosensor Incorporated Artificial Intelligence Technique

COVID-19, continually developing and raising increasingly significant issues, has impacted human health and caused countless deaths. It is an infectious disease with a high incidence and mortality rate. The spread of the disease is also a significant threat to human health, especially in the developing world. This study suggests a method called shuffle shepherd optimization-based generalized deep convolutional fuzzy network (SSO-GDCFN) to diagnose the COVID-19 disease state, types, and recovered categories. The results show that the accuracy of the proposed method is as high as 99.99%; similarly, precision is 99.98%; sensitivity/recall is 100%; specificity is 95%; kappa is 0.965%; AUC is 0.88%; and MSE is less than 0.07% as well as 25 s. Moreover, the performance of the suggested method has been confirmed by comparison of the simulation results from the proposed approach with those from several traditional techniques. The experimental findings demonstrate strong performance and high accuracy for categorizing COVID-19 stages with minimal reclassifications over the conventional methods.

[1]  Krishnendu Pal,et al.  Novel electrochemical biosensor key significance of smart intelligence (IoMT & IoHT) of COVID-19 virus control management , 2022, Process Biochemistry.

[2]  Mohamed Omran,et al.  Current trends in COVID-19 diagnosis and its new variants in physiological fluids: Surface antigens, antibodies, nucleic acids, and RNA sequencing , 2022, TrAC Trends in Analytical Chemistry.

[3]  R. Chauhan,et al.  Nanobioengineering: A promising approach for early detection of COVID-19 , 2022, Sensing Tools and Techniques for COVID-19.

[4]  S. P. Thipperudraswamy,et al.  Artificial Intelligence (AI) and Internet of Medical Things (IoMT) Assisted Biomedical Systems for Intelligent Healthcare , 2022, Biosensors.

[5]  Md. Sahidul Islam,et al.  Humoral and Cellular Immune Responses of COVID-19 vaccines against SARS-Cov-2 Omicron variant: a systemic review , 2022, International journal of biological sciences.

[6]  Omneya Attallah,et al.  A wavelet-based deep learning pipeline for efficient COVID-19 diagnosis via CT slices , 2022, Applied Soft Computing.

[7]  Omneya Attallah,et al.  An Intelligent ECG-Based Tool for Diagnosing COVID-19 via Ensemble Deep Learning Techniques , 2022, Biosensors.

[8]  M. Elhoseny,et al.  Advanced Cognitive Algorithm for Biomedical Data Processing: COVID-19 Pattern Recognition as a Case Study , 2022, Journal of healthcare engineering.

[9]  Sivaji Bandyopadhyay,et al.  Perspective of AI system for COVID-19 detection using chest images: a review , 2022, Multimedia Tools and Applications.

[10]  E. Valera,et al.  Microfluidic point-of-care device for detection of early strains and B.1.1.7 variant of SARS-CoV-2 virus. , 2022, Lab on a chip.

[11]  M. Rajesh,et al.  Integrating bio medical sensors in detecting hidden signatures of COVID-19 with Artificial intelligence , 2022, Measurement.

[12]  V. Munster,et al.  OraSure InteliSwab™ Rapid Antigen Test Performance with the SARS-CoV-2 Variants of Concern—Alpha, Beta, Gamma, Delta, and Omicron , 2022, Viruses.

[13]  P. Austin,et al.  Effectiveness of COVID-19 vaccines against symptomatic SARS-CoV-2 infection and severe outcomes with variants of concern in Ontario , 2022, Nature Microbiology.

[14]  V. Munster,et al.  OraSure InteliSwab® Rapid Antigen Test performance with the SARS-CoV-2 Variants of Concern Alpha, Beta, Gamma, Delta, and Omicron , 2022, medRxiv.

[15]  Chih-Cheng Huang,et al.  Saliva-based COVID-19 detection: A rapid antigen test of SARS-CoV-2 nucleocapsid protein using an electrical-double-layer gated field-effect transistor-based biosensing system , 2022, Sensors and Actuators B: Chemical.

[16]  O. Krejcar,et al.  Biosensors as Nano-Analytical Tools for COVID-19 Detection , 2021, Sensors.

[17]  M. Khan,et al.  Wearable Piezoelectric BioMEMS-based Sensor for SARS-CoV-2 (COVID-19) Virus Droplets Detection , 2021, 2021 IEEE 15th International Conference on Nano/Molecular Medicine & Engineering (NANOMED).

[18]  M. Zamzami,et al.  Carbon nanotube field-effect transistor (CNT-FET)-based biosensor for rapid detection of SARS-CoV-2 (COVID-19) surface spike protein S1 , 2021, Bioelectrochemistry.

[19]  F. Izzo,et al.  Artificial Intelligence and COVID-19 Using Chest CT Scan and Chest X-ray Images: Machine Learning and Deep Learning Approaches for Diagnosis and Treatment , 2021, Journal of personalized medicine.

[20]  Fadi Al-Turjman,et al.  Crispr biosensing and Ai driven tools for detection and prediction of Covid-19 , 2021, J. Exp. Theor. Artif. Intell..

[21]  A. Alhossan,et al.  An Efficient CNN Model for COVID-19 Disease Detection Based on X-Ray Image Classification , 2021, Complex..

[22]  S. Fong,et al.  Artificial intelligence in the diagnosis of COVID-19: challenges and perspectives , 2021, International journal of biological sciences.

[23]  Eun Seong Kim,et al.  Ultra-fast and recyclable DNA biosensor for point-of-care detection of SARS-CoV-2 (COVID-19) , 2021, Biosensors and Bioelectronics.

[24]  M. Kavitha,et al.  COVID-19 Disease Diagnosis using Smart Deep Learning Techniques , 2021 .

[25]  Wei Gao,et al.  Emerging Telemedicine Tools for Remote COVID-19 Diagnosis, Monitoring, and Management , 2020, ACS nano.

[26]  Nam-Young Kim,et al.  Electrochemical SARS-CoV-2 Sensing at Point-of-Care and Artificial Intelligence for Intelligent COVID-19 Management , 2020, ACS applied bio materials.

[27]  Chun-Ka Wong,et al.  Artificial intelligence mobile health platform for early detection of COVID-19 in quarantine subjects using a wearable biosensor: protocol for a randomised controlled trial , 2020, BMJ Open.

[28]  D. Browne,et al.  Risk and resilience in family well-being during the COVID-19 pandemic. , 2020, The American psychologist.

[29]  E. Behr,et al.  SARS-CoV-2, COVID-19, and inherited arrhythmia syndromes , 2020, Heart Rhythm.

[30]  C. Langenberg,et al.  SARS-CoV-2 (COVID-19): What Do We Know About Children? A Systematic Review , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[31]  Sy Lim,et al.  The Applications of Biosensing and Artificial Intelligence Technologies for Rapid Detection and Diagnosis of COVID-19 in Remote Setting , 2020 .

[32]  K. Lohr,et al.  Screening for Speech and Language Delay in Children 5 Years Old and Younger: A Systematic Review , 2015, Pediatrics.

[33]  K. Lohr,et al.  Screening for Speech and Language Delays and Disorders in Children Age 5 Years or Younger: A Systematic Review for the U.S. Preventive Services Task Force , 2015 .